CRW vs. EMIS, INS, KOO, RENX, COG, INHC, FDBK, IQAI, TRLS, and DVRG
Should you be buying Craneware stock or one of its competitors? The main competitors of Craneware include EMIS Group (EMIS), Instem (INS), Kooth (KOO), Renalytix (RENX), Cambridge Cognition (COG), Induction Healthcare Group (INHC), Feedback (FDBK), IQ-AI (IQAI), Trellus Health (TRLS), and DeepVerge (DVRG). These companies are all part of the "health information services" industry.
Craneware vs. Its Competitors
EMIS Group (LON:EMIS) and Craneware (LON:CRW) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, media sentiment, institutional ownership, valuation, earnings, risk, profitability and dividends.
In the previous week, Craneware had 1 more articles in the media than EMIS Group. MarketBeat recorded 1 mentions for Craneware and 0 mentions for EMIS Group. Craneware's average media sentiment score of 0.75 beat EMIS Group's score of 0.00 indicating that Craneware is being referred to more favorably in the news media.
105.6% of EMIS Group shares are owned by institutional investors. Comparatively, 33.1% of Craneware shares are owned by institutional investors. 3.6% of EMIS Group shares are owned by company insiders. Comparatively, 10.2% of Craneware shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
EMIS Group has higher earnings, but lower revenue than Craneware. EMIS Group is trading at a lower price-to-earnings ratio than Craneware, indicating that it is currently the more affordable of the two stocks.
EMIS Group has a net margin of 17.23% compared to Craneware's net margin of 6.18%. EMIS Group's return on equity of 23.17% beat Craneware's return on equity.
EMIS Group has a beta of -0.13, indicating that its share price is 113% less volatile than the S&P 500. Comparatively, Craneware has a beta of 0.28, indicating that its share price is 72% less volatile than the S&P 500.
Craneware has a consensus price target of GBX 2,725, indicating a potential upside of 20.04%. Given Craneware's stronger consensus rating and higher probable upside, analysts plainly believe Craneware is more favorable than EMIS Group.
EMIS Group pays an annual dividend of GBX 42 per share. Craneware pays an annual dividend of GBX 0.37 per share and has a dividend yield of 0.0%. EMIS Group pays out 8,936.2% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Craneware pays out 86.5% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Craneware is clearly the better dividend stock, given its higher yield and lower payout ratio.
Summary
Craneware beats EMIS Group on 11 of the 17 factors compared between the two stocks.
Get Craneware News Delivered to You Automatically
Sign up to receive the latest news and ratings for CRW and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding CRW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Craneware Competitors List
Related Companies and Tools
This page (LON:CRW) was last updated on 9/13/2025 by MarketBeat.com Staff
Free CRW Stock Alerts